{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T05:04:39Z","timestamp":1780031079007,"version":"3.53.1"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Central nervous system (CNS) involvement is a critical prognostic factor in childhood acute lymphoblastic leukemia (ALL). Conventional cytology remains the diagnostic standard, but its limited sensitivity may lead to underdetection of CNS disease. This study evaluated the incidence and prognostic impact of CNS involvement at diagnosis and relapse in a Mexican pediatric cohort, focusing on the relationship between baseline CNS status and subsequent relapse.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of 73 children (&amp;lt;15 years) diagnosed with ALL at a national tertiary referral center between 2019 and 2020, with a five-year follow-up. CNS involvement was defined by cerebrospinal fluid cytology and classified as CNS-1, CNS-2, and CNS-3 according to international criteria. Incidence at diagnosis, CNS relapse during follow-up, and cumulative CNS involvement were estimated. CNS relapse was analyzed among patients achieving complete remission (n =57), excluding early deaths, to define the at-risk population. Survival was analyzed using Kaplan\u2013Meier estimates and the log-rank test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At diagnosis, CNS involvement occurred in 2.9% of evaluable patients (n =2\/69; 95% CI: 0.8\u20139.5%), while 33.3% of patients were classified as CNS-2. During follow-up, CNS relapse occurred in 17.5% (n =10\/57; 95% CI: 9.4\u201328.9%), with a cumulative proportion of 16.4% (n =12\/73; 95% CI: 9.3\u201326.2%). Half of CNS relapses occurred in patients initially classified as CNS-2. CNS-3 status at diagnosis was associated with significantly inferior overall survival (log-rank, p = 0.007).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings identify a marked discordance between baseline CNS detection and subsequent relapse burden. The observed relapse burden in a cohort with a high prevalence of CNS-2 at presentation raises the possibility that conventional criteria may underestimate clinically relevant CNS disease in some patients. Prospective studies incorporating more sensitive diagnostic approaches are warranted to clarify the clinical implications of low-level cerebrospinal fluid blast detection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1813121","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:43:56Z","timestamp":1780029836000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Discrepancy between central nervous system involvement at diagnosis and relapse burden in childhood acute lymphoblastic leukemia: a five-year cohort study in a middle-income setting"],"prefix":"10.3389","volume":"16","author":[{"given":"Carmen Gabriela","family":"Torres-Alarc\u00f3n","sequence":"first","affiliation":[{"name":"Department of Blood Bank, Hospital Central Militar","place":["M\u00e9xico City, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Sandoval-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital General de Naucalpan","place":["Naucalpan de Ju\u00e1rez, Estado de M\u00e9xico, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1053\/j.seminoncol.2009.05.002","article-title":"Central nervous system disease in hematologic Malignancies: historical perspective and practical applications","volume":"36","author":"Pui","year":"2009","journal-title":"Semin Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70069-6","article-title":"Current management and challenges of Malignant disease in the CNS in paediatric leukaemia","volume":"9","author":"Pui","year":"2008","journal-title":"Lancet Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197303)31:3<520::AID-CNCR2820310306>3.0.CO;2-2","article-title":"The central nervous system in childhood leukemia. I. The arachnoid","volume":"31","author":"Price","year":"1973","journal-title":"Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05773.x","article-title":"Childhood acute lymphoblastic leukaemia and relapse","volume":"131","author":"Gaynon","year":"2005","journal-title":"Br J Haematol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-04-082040","article-title":"Submicroscopic bone marrow involvement in isolated extramedullary relapses in childhood acute lymphoblastic leukemia: a more precise definition of \u2018isolated\u2019 and its possible clinical implications, a collaborative study of the Resistant Disease Committee","volume":"110","author":"Hagedorn","year":"2007","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25363","article-title":"Detection of central nervous system involvement in childhood acute lymphoblastic leukemia by cytomorphology and flow cytometry of the cerebrospinal fluid","volume":"62","author":"Ranta","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01714-x","article-title":"Central nervous system involvement in childhood acute lymphoblastic leukemia: challenges and solutions","volume":"36","author":"Thastrup","year":"2022","journal-title":"Leukemia"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00070","article-title":"Detection of central nervous system infiltration by myeloid and lymphoid hematologic neoplasms using flow cytometry analysis: diagnostic accuracy study","volume":"5","author":"Bento","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.2850","article-title":"Influence of cranial radiotherapy on outcome in children with acute lymphoblastic leukemia treated with contemporary therapy","volume":"34","author":"Vora","year":"2016","journal-title":"J Clin Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0570-1","article-title":"Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology study","volume":"34","author":"Thastrup","year":"2019","journal-title":"Leukemia"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-09-670729","article-title":"Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000","volume":"127","author":"Moricke","year":"2016","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.096","article-title":"Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture","volume":"21","author":"B\u00fcrger","year":"2003","journal-title":"J Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.943761","article-title":"Prognostic significance of CNSL at diagnosis of childhood B-cell acute lymphoblastic leukemia: a report from the South China Children\u2019s Leukemia Group","volume":"12","author":"Xu","year":"2022","journal-title":"Front Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.5581\/1516-8484.20120109","article-title":"Incidence and risk factors for central nervous system relapse in children and adolescents with acute lymphoblastic leukemia","volume":"34","author":"Cancela","year":"2012","journal-title":"Rev Bras Hematol Hemoter"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1219904","article-title":"Early mortality in children with acute lymphoblastic leukemia in a developing country: the role of malnutrition at diagnosis. A multicenter cohort MIGICCL study","volume":"58","author":"Mart\u00edn-Trejo","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23407","article-title":"Detection of occult cerebrospinal fluid involvement during maintenance therapy identifies a group of children with acute lymphoblastic leukemia at high risk for relapse","volume":"88","author":"Mart\u00ednez-Laperche","year":"2013","journal-title":"Am J Hematol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26128","article-title":"Leukemic blasts are present at low levels in spinal fluid in one\u2010third of childhood acute lymphoblastic leukemia cases","volume":"63","author":"Levinsen","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2017-0167-CP","article-title":"Performance characteristics of cerebrospinal fluid cytology: an analysis of responses from the college of American Pathologists Nongynecologic Cytopathology Education program","volume":"142","author":"Tabatabai","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-01029-9","article-title":"Flowcytometric evaluation of cerebrospinal fluid in childhood ALL identifies CNS involvement better then conventional cytomorphology","volume":"35","author":"de Haas","year":"2021","journal-title":"Leukemia"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24981","article-title":"Clinical features and early treatment response of central nervous system involvement in childhood acute lymphoblastic leukemia","volume":"61","author":"Levinsen","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2025.287392","article-title":"Flow cytometric analysis of cerebrospinal fluid identifies patients with occult central nervous system involvement in relapsed pediatric acute lymphoblastic leukemia","volume":"111","author":"Thastrup","year":"2025","journal-title":"Haematologica"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2022.113344","article-title":"Stabilization of leukocytes from cerebrospinal fluid for central immunophenotypic evaluation in multicenter clinical trials","volume":"510","author":"Mexhitaj","year":"2022","journal-title":"J Immunol Methods"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-01-024729","article-title":"Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children\u2019s Cancer Group (CCG)","volume":"109","author":"Schultz","year":"2007","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02892","article-title":"Impact of intrathecal triple therapy versus intrathecal methotrexate on disease-free survival for high-risk B-lymphoblastic leukemia: Children\u2019s Oncology Group Study AALL1131","volume":"38","author":"Salzer","year":"2020","journal-title":"J Clin Oncol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3324\/HAEMATOL.2022.281788","article-title":"Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemia","volume":"108","author":"Heilmann","year":"2023","journal-title":"Haematologica"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29256","article-title":"Late isolated central nervous system relapse in childhood B-cell acute lymphoblastic leukemia treated with intensified systemic therapy and delayed reduced dose cranial radiation: a report from the Children\u2019s Oncology Group study AALL02P2","volume":"68","author":"Hastings","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1254233","article-title":"Retrospective analysis of outcomes for pediatric acute lymphoblastic leukemia in South American centers","volume":"13","author":"Duffy","year":"2023","journal-title":"Front Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30273-6","article-title":"Global childhood cancer survival estimates and priority-setting: a simulation-based analysis","volume":"20","author":"Ward","year":"2019","journal-title":"Lancet Oncol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16111988","article-title":"Prevalence and treatment outcomes of childhood acute lymphoblastic leukemia in Kosovo","volume":"16","author":"Pasha","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-025-13729-5","article-title":"Nutritional status at diagnosis and its relationship with survival and relapse in Mexican children with acute lymphoblastic leukemia: a retrospective study","volume":"25","author":"Guzm\u00e1n-Le\u00f3n","year":"2025","journal-title":"BMC Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-020-02408-y","article-title":"Leukemia mortality in children from Latin America: trends and predictions to 2030","volume":"20","author":"Torres-Roman","year":"2020","journal-title":"BMC Pediatr"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1255555","article-title":"Evaluation of factors leading to poor outcomes for pediatric acute lymphoblastic leukemia in Mexico: a multi-institutional report of 2,116 patients","volume":"13","author":"Moreira","year":"2023","journal-title":"Front Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1813121\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:44:08Z","timestamp":1780029848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1813121\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":32,"alternative-id":["10.3389\/fonc.2026.1813121"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1813121","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"article-number":"1813121"}}